Lisa Conte

President, Chief Executive Officer, Member of Board of Directors at Jaguar Animal Health

Lisa Conte is a prominent figure in the pharmaceutical industry, serving as the President, Chief Executive Officer, and a Member of the Board of Directors at Jaguar Animal Health, a company she founded in 2013. Jaguar Animal Health focuses on developing plant-based prescription medicines for animals, particularly targeting gastrointestinal issues.

Background and Education

Conte has a rich background in pharmaceuticals, having previously founded Shaman Pharmaceuticals in 1989 and Napo Pharmaceuticals in 2001. She has been instrumental in pioneering the use of natural treatments derived from plants for various health needs. Her educational credentials include an MBA and an undergraduate degree from Dartmouth College, as well as a graduate degree from the University of California, San Diego.1 3

Career Highlights

Founder of Jaguar Animal Health: Established to commercialize plant-based medicines for veterinary use, including products like Canalevia for treating diarrhea in dogs.
Napo Pharmaceuticals: Focused on human health, particularly gastrointestinal disorders; its lead product, Mytesi (crofelemer), is FDA-approved for treating diarrhea related to HIV/AIDS treatment.2 4
Innovative Approach: Conte emphasizes the importance of supportive care in healthcare, advocating for treatments that enhance the quality of life for patients and animals alike.2 3

Current Focus

Under Conte's leadership, Jaguar Animal Health continues to explore new avenues in both human and animal health sectors. The company is preparing for the upcoming launch of Gelclair, an FDA-approved product for mucositis, and is involved in several clinical trials aimed at addressing rare diseases.5 6

Leadership Philosophy

Conte's leadership style is characterized by a commitment to innovation and a focus on natural remedies. She believes in maintaining clarity of purpose within her organization to navigate challenges effectively.2 3

In summary, Lisa Conte's extensive experience and dedication to plant-based pharmaceuticals have positioned her as a significant leader in both human and veterinary medicine.